Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4

This publication has 11 references indexed in Scilit:

• Vitamin D analogues: how do they differ and what is their clinical role?
  Nephrology Dialysis Transplantation, 2001
• Safety and efficacy of oral calcitriol (1, 25 -dihydroxyvitamin D₃) for the treatment of psoriasis
  British Journal of Dermatology, 1996
• Low-dose calcitriol prevents the rise in 1,84 iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial)
  Nephrology Dialysis Transplantation, 1995
• Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure
  BMJ, 1995
• Bone Mineral Density Evaluated by Dual-Energy X-Ray Absorptiometry after One-Year Treatment with Calcitriol Started in the Predialysis Phase of Chronic Renal Failure
  Nephron, 1995
• Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis
  Nephrology Dialysis Transplantation, 1994
• The spectrum of bone disease in end-stage renal failure—An evolving disorder
  Kidney International, 1993
• 1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial
  Kidney International, 1989
• Low Dose CalcitriolVersusPlacebo in Patients with Predialysis Chronic Renal Failure*
  Journal of Clinical Endocrinology & Metabolism, 1988
• 1,25(OH)₂D₃ and Renal Function
  Acta Medica Scandinavica, 1982